Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation
- 1 December 2002
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 30 (12) , 945-951
- https://doi.org/10.1038/sj.bmt.1703770
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 30 references indexed in Scilit:
- NON-PARAMETRIC INFERENCE FOR CUMULATIVE INCIDENCE FUNCTIONS IN COMPETING RISKS STUDIESStatistics in Medicine, 1997
- Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infectionBone Marrow Transplantation, 1997
- Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantationThe Lancet, 1994
- Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind TrialAnnals of Internal Medicine, 1993
- Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow TransplantAnnals of Internal Medicine, 1993
- Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantationEuropean Journal of Haematology, 1991
- Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infectionBritish Journal of Haematology, 1991
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host diseaseBlood, 1986
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986